Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

Clinical trial NCT05074810 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05074810
Sponsor: Verastem, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer KRAS Activating Mutation

Start date: 2022-04-12
Primary completion: 2026-06-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.